STONEPINE CAPITAL MANAGEMENT, LLC CTI BioPharma Corp. Transaction History

STONEPINE CAPITAL MANAGEMENT, LLC portfolio value:

$32.99M
portfolio value

STONEPINE CAPITAL MANAGEMENT, LLC quarter portfolio value change:

-2.51%
quarter

CTI BioPharma Corp. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +54.01% 1.98M shares 11.01M $5.82 5.66M
Q2 2022 share Decrease -21.42% -1.00M shares 101K $5.97 3.68M
Q1 2022 share Decrease -46.77% -4.11M shares 51K $4.67 4.68M
Q4 2021 share Increase +10.50% 836.02K shares -1.67M $2.48 8.80M
Q3 2021 share Increase +4.35% 331.79K shares 4.41M $2.95 7.96M
Q2 2021 share Increase +131.75% 4.33M shares 9.49M $2.5 7.63M
Q1 2021 share Increase +60.34% 1.23M shares 2.97M $2.91 3.29M
Q4 2020 share Decrease -45.50% -1.71M shares -1.48M $3.22 2.05M
Q3 2020 share Decrease -7.36% -299.59K shares 3.38M $2.15 3.76M
Q2 2020 share Decrease -36.74% -2.36M shares -1.19M $1.16 4.06M
Q1 2020 share Increase +71.26% 2.67M shares -17K $0.92 6.43M
Q4 2019 share Increase +1.16% 43.00K shares 2.82M $1.58 3.75M
Q3 2019 share Decrease -4.93% -192.40K shares -248K $0.84 3.71M
Q2 2019 share Decrease -2.39% -95.6K shares -526K $0.86 3.90M
Q1 2019 share Decrease -30.15% -1.72M shares -320K $0.97 4M
Q4 2018 share Increase +8.01% 424.51K shares -7.25M $0.73 5.72M
Q3 2018 share Increase +30.94% 1.25M shares -8.71M $2.16 5.30M
Q2 2018 share Decrease -21.25% -1.09M shares 113K $4.98 4.04M
Q1 2018 share Increase +180.23% 3.30M shares 15.13M $3.9 5.14M
Q4 2017 share Increase +84.78% 841.83K shares 1.74M $2.68 1.83M
Q3 2017 share Decrease -56.53% -1.29M shares -4.39M $3.19 993K
Q2 2017 share Increase 0.00% 2.28M shares 7.56M $3.31 2.28M